Developmental pathways in the pathogenesis of lung fibrosis

Area of Science:

• Pulmonology
• Fibrosis Research
• Aging and Disease

Background:

• Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with limited treatment options.
• IPF predominantly affects individuals over 65, characterized by excessive extracellular matrix deposition and impaired lung function.
• The disease arises from a complex interplay of aging, genetic factors, chronic injury, oxidative stress, and failed regeneration.

Purpose of the Study:

• To review current knowledge on IPF pathogenesis from basic and clinical research.
• To provide novel insights into the disease mechanisms driving pulmonary fibrosis.
• To identify potential therapeutic targets and approaches for IPF treatment.

Main Methods:

• Comprehensive literature review of basic and clinical research on IPF.
• Analysis of genetic and molecular pathways implicated in lung development and IPF.
• Synthesis of data on risk factors including aging, genetics, and environmental exposures.

Main Results:

• IPF pathogenesis involves activated fibroblasts and myofibroblasts leading to excessive extracellular matrix deposition.
• A pro-fibrotic lung environment is orchestrated by aging, genetic predisposition, oxidative stress, and impaired repair mechanisms.
• Genes and networks crucial for lung development are aberrantly activated in IPF.

Conclusions:

• Understanding the complex etiology of IPF is crucial for developing effective treatments.
• Targeting fibrotic processes and aberrant gene networks offers potential therapeutic avenues.
• Further research integrating basic science and clinical findings is needed to combat pulmonary fibrosis.